News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
36,934 Results
Type
Article (2935)
Company Profile (2)
Press Release (33997)
Section
Business (9404)
Career Advice (200)
Deals (2223)
Drug Delivery (20)
Drug Development (5894)
Employer Resources (33)
FDA (968)
Job Trends (1057)
News (18495)
Policy (1946)
Tag
Academia (204)
Accelerated approval (2)
Adcomms (8)
Allergies (11)
Alliances (2297)
ALS (13)
Alzheimer's disease (109)
Antibody-drug conjugate (ADC) (20)
Approvals (952)
Artificial intelligence (40)
Autoimmune disease (10)
Bankruptcy (38)
Best Places to Work (874)
BIOSECURE Act (5)
Biosimilars (9)
Biotechnology (2)
Bladder cancer (15)
Brain cancer (3)
Breast cancer (42)
Cancer (318)
Cardiovascular disease (32)
Career advice (166)
Career pathing (2)
CAR-T (22)
CDC (9)
Cell therapy (53)
Cervical cancer (2)
Clinical research (5105)
Collaboration (84)
Compensation (16)
Complete response letters (9)
COVID-19 (202)
CRISPR (5)
C-suite (28)
Cystic fibrosis (11)
Data (539)
Denatured (4)
Depression (10)
Diabetes (59)
Diagnostics (372)
Digital health (1)
Diversity (1)
Diversity, equity & inclusion (17)
Drug discovery (16)
Drug pricing (18)
Drug shortages (4)
Duchenne muscular dystrophy (14)
Earnings (5039)
Editorial (8)
Employer branding (2)
Employer resources (30)
Events (4040)
Executive appointments (35)
FDA (1195)
Frontotemporal dementia (3)
Funding (57)
Gene editing (15)
Generative AI (6)
Gene therapy (50)
GLP-1 (121)
Government (334)
Guidances (53)
Healthcare (1061)
HIV (7)
Huntington's disease (5)
IgA nephropathy (4)
Immunology and inflammation (18)
Immuno-oncology (4)
Indications (11)
Infectious disease (225)
Inflammatory bowel disease (14)
Influenza (12)
Intellectual property (12)
Interviews (20)
IPO (1129)
IRA (6)
Job creations (207)
Job search strategy (135)
JPM (1)
Kidney cancer (1)
Labor market (1)
Layoffs (55)
Leadership (4)
Legal (534)
Liver cancer (6)
Lung cancer (57)
Lymphoma (21)
Machine learning (3)
Management (12)
Manufacturing (48)
MASH (6)
Medical device (674)
Medtech (687)
Mergers & acquisitions (1141)
Metabolic disorders (144)
Multiple sclerosis (12)
NASH (1)
Neurodegenerative disease (10)
Neuropsychiatric disorders (7)
Neuroscience (191)
NextGen: Class of 2026 (301)
Non-profit (209)
Obesity (77)
Opinion (33)
Ovarian cancer (8)
Pain (23)
Pancreatic cancer (9)
Parkinson's disease (16)
Partnered (2)
Patents (25)
Patient recruitment (30)
Peanut (4)
People (1801)
Pharmacy benefit managers (3)
Phase 1 (1408)
Phase 2 (2278)
Phase 3 (1896)
Pipeline (457)
Policy (30)
Postmarket research (181)
Preclinical (539)
Press Release (4)
Prostate cancer (14)
Psychedelics (12)
Radiopharmaceuticals (19)
Rare diseases (70)
Real estate (308)
Recruiting (8)
Regulatory (1400)
Reports (8)
Research institute (173)
Resumes & cover letters (52)
RNA editing (3)
RSV (11)
Schizophrenia (11)
Series A (10)
Series B (11)
Sickle cell disease (7)
Special edition (2)
Spinal muscular atrophy (19)
Sponsored (5)
Startups (301)
Stomach cancer (3)
Supply chain (5)
Tariffs (5)
The Weekly (10)
Vaccines (84)
Venture capital (5)
Weight loss (44)
Women's health (7)
Worklife (1)
Date
Last 7 days (35)
Last 30 days (112)
Last 365 days (1855)
2026 (158)
2025 (1872)
2024 (2138)
2023 (2228)
2022 (2992)
2021 (2942)
2020 (2900)
2019 (2564)
2018 (2078)
2017 (1840)
2016 (1889)
2015 (2171)
2014 (1475)
2013 (1179)
2012 (1204)
2011 (1325)
2010 (1111)
Location
Africa (54)
Alabama (3)
Arizona (4)
Asia (1982)
Australia (341)
California (583)
Canada (232)
China (59)
Colorado (23)
Connecticut (28)
Delaware (13)
Europe (5474)
Florida (116)
Georgia (43)
Hawaii (1)
Idaho (4)
Illinois (47)
India (3)
Indiana (28)
Japan (38)
Kansas (4)
Kentucky (1)
Louisiana (1)
Maryland (58)
Massachusetts (438)
Michigan (17)
Minnesota (25)
Missouri (5)
Montana (2)
Nevada (9)
New Hampshire (7)
New Jersey (165)
New Mexico (2)
New York (166)
North Carolina (78)
Northern California (280)
Ohio (4)
Oregon (4)
Pennsylvania (127)
Rhode Island (4)
South America (69)
South Carolina (5)
Southern California (241)
Tennessee (15)
Texas (146)
United States (2197)
Utah (34)
Virginia (6)
Washington D.C. (9)
Washington State (38)
Wisconsin (5)
36,934 Results for "bia separations".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bial Achieves Key Milestone in Phase 2b ACTIVATE Study of BIA 28-6156 in GBA1-Associated Parkinson’s Disease
January 27, 2026
·
4 min read
Press Releases
Key Milestone in ACTIVATE Phase 2 Clinical Trial of BIA 28-6156
October 2, 2025
·
3 min read
Press Releases
Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company
December 2, 2025
·
5 min read
Press Releases
Johnson & Johnson Announces Intent to Separate Its Orthopaedics Business
October 15, 2025
·
9 min read
Biotech Bay
Teknova and Sartorius BIA Separations Share Data Demonstrating Reliable and Scalable Approach for the Enhancement of AAV Full Capsid Enrichment with an Optimized AEX Platform
Alpha Teknova, Inc., and Sartorius BIA Separations, which is part of the international life science group Sartorius, shared new data that demonstrates the ability to improve the recovery of full AAV capsids during anion-exchange purification, which will help gene therapy companies streamline the downstream processing workflow.
July 20, 2023
·
4 min read
Press Releases
Relmada Therapeutics Provides Regulatory Update Confirming FDA Alignment on Registrational Studies Design for NDV-01 for Two Separate Indications
January 12, 2026
·
6 min read
Biotech Bay
Teknova and Sartorius BIA Separations Announce Collaboration to Address Critical Pain Point in Gene Therapy Process Development
Alpha Teknova, Inc., and Sartorius BIA Separations, which is part of the international life science group Sartorius, announced that the companies have entered into a collaboration arrangement that will help gene therapy companies streamline the downstream purification process.
March 15, 2023
·
4 min read
Cytomos selected to showcase CDS cell analysis technology at BIA’s BioProcessUK Dragon’s Den session
Biotech company, Cytomos (www.cytomotos.com) is pleased to announce that it has been selected to showcase its dielectric spectroscopy (CDS) platform at the BIA’s BioProcessUK Dragon’s Den
October 24, 2023
·
3 min read
Press Releases
Innovent Biologics Announces U.S. FDA IND Approval for the First Global MRCT Phase 3 Study (MarsLight-11) of IBI363 (PD-1/IL-2α-bias) in Squamous Non-Small Cell Lung Cancer
August 24, 2025
·
8 min read
Press Releases
ALX Oncology Advances Separate Clinical Trials Evaluating Investigational CD47-Inhibitor Evorpacept and Novel EGFR-Targeted Antibody-Drug Conjugate ALX2004
January 9, 2026
·
5 min read
1 of 3,694
Next
